Delivery Order SPE2DB22D3016-SPE2DB25FBDL1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,410.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,143.52 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL dosage). This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections, with a contract ceiling value of $3,003.00. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $2,702.70. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, issued on July 18, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,494.17 by the Defense Logistics Agency on July 31, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a 0.5 ml dosage. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,356.84 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This contract represents a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded a $3,453.76 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDL1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors, valued at $2,775.42 with a firm fixed price. The award was made on July 29, 2025, with an ultimate completion date of July 30, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical federal medical procurement vendor, supplying a broad portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's IDC with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains. As a leading provider in the federal pharmaceutical supply chain, AmerisourceBergen regularly fulfills delivery orders ranging from small transactions to substantial orders, demonstrating its capability to meet diverse federal medical supply requirements through open competition with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/29/25 |